Please login to the form below

Not currently logged in
Email:
Password:

Blue Rubicon buys Open Road

Acquisition creates an ‘independent powerhouse’, say the agencies.
Blue Rubicon Open Road

Blue Rubicon, which recently opened offices in Doha and Dubai, plans to extend its existing strategic, corporate and crisis communications offer through its acquisition of London agency Open Road.

The newly combined business will boast 200 staff and be 'capable of advising at the most senior levels across the world's leading businesses and institutions', Blue Rubicon and Open Road said in a joint statement.

In addition to strengthening existing offerings, the company plans to add new capabilities, including public affairs, employee engagement and healthcare communications in the UK, along with, hopefully, supporting clients in Brussels and Washington in the future.

“We're bringing together two independent consultancies with a similar mind-set, approach, reputation and strategic communications offer,” said Blue Rubicon CEO, Gordon Tempest Hay.

“Without question, Open Road is the stand-out independent political and regulatory advisory firm in the market and we're delighted to have them become part of the Blue Rubicon family.”

While forming part of the Blue Rubicon family, Open Road will initially retain its name and location.

“We believe we have found the perfect partner in Blue Rubicon. We are very excited about the synergies between the two agencies and about what we believe we can achieve together,” said Graham McMillan, Open Road CEO, who will report to Tempest Hay.

The acquisition is the latest step in Blue Rubicon's strategy of investing in important markets as it works to become a global leader in transforming and enhancing reputations.

Further international expansion is expected in the coming year, Tempest Hay told PMLiVE: “We hope to open offices in Singapore, Brussels, DC and possibly NYC in the future”.

“We'll be focused on achieving a successful integration of the consultancies over the months to come. Our first priorities will be bringing the teams together as part of a family that is able to advise holistically across the full landscape,” he said.

Article by
Tara Craig

14th February 2014

From: Marketing

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Frontera Group

Welcome to Frontera Group, where our agencies immerse you in the world of the patient...

Latest intelligence

Has the pandemic opened up a future of accelerated diagnosis and better care for rare disease patients?
The challenge with rare disease is in the name – it's rare, so awareness is limited and diagnosis hindered. Could a more virtual existence change this? A Medical Affairs viewpoint...
The other side of … blood cancer
To stay motivated for the fight, some patients need to feel like active players in the treatment journey, not passengers to every decision....
COVID clinical trial
COVID-19 – a catalyst for technology adoption in clinical trials
As the COVID-19 crisis disrupts clinical trials around the globe, it is also proving to be a catalyst that may transform its approach to trials for good...

Infographics